IRCT20231026059867N1 IRCT 2023-11-08 Esfahan University of Medical Sciences Oral and injectable antiquaguane in the prevention of thromboembolic events Comparison of the effects of oral and injectable antiquaguane in the prevention of thromboembolic events in patients with gynecological cancers who underwent surgery. 2023-12-22 anticipated 100 Complete https://irct.ir/trial/73395 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is simple and done with the help of a table of random numbers. According to the number of participants in the study, a sequence of random numbers is created with the help of a random number table, and each number is placed in an aluminum envelope, and the back of the envelopes is numbered according to the sequence process. According to the order of entry into the study, an envelope is opened and the sequence number inside is determined. If the number is even, the person will be placed in the second group, and if the number is odd, the person will be placed in the first group. 2-3 Condition 1: Thrombosis. Condition 2: Pulmonary embolism. Intervention 1: Intervention group: Receiving the oral anticoagulant apixaban tablets made in Elixir Pharmaceutical Company, 2.5 mg twice a day for 3 months. Intervention 2: Intervention group: Received the subcutaneous anticoagulant enoxaparin ampoule manufactured in Octorco pharmaceutical company, 40 mg once a day for 3 months. No - There is not a plan to make this available Justification or reason for not sharing IPD is No more information